SEC Form 4 · accession 0001646649-26-000032
Natera, Inc. · NTRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Sheena
Director · Other
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 9:35 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001604821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 15, 2026 | S | 6,000 | $350.0718 | D | 224,464 | D | |
| Common StockF1 | Sep 16, 2026 | S | 200 | $348.025 | D | 224,264 | D | |
| Common StockF1 | Sep 16, 2026 | S | 100 | $349.045 | D | 224,164 | D | |
| Common StockF1,F3 | Sep 16, 2026 | S | 1,400 | $353.83 | D | 222,764 | D | |
| Common StockF1,F4 | Sep 16, 2026 | S | 450 | $354.9133 | D | 222,314 | D | |
| Common StockF1,F5 | Sep 16, 2026 | S | 800 | $355.9475 | D | 221,514 | D | |
| Common StockF1,F6 | Sep 16, 2026 | S | 200 | $356.8664 | D | 221,314 | D | |
| Common StockF7 | holding | — | — | — | 18,032 | I | By Caraluna 1 Trust | |
| Common StockF7 | holding | — | — | — | 18,032 | I | By Caraluna 2 Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
- F2The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.1750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.2700 to $354.2450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.54 to $355.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.7350 to $356.6550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.7150 to $357.0600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.